Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
700.00    0.00 (0.00%)
Bid:
690.00
Ask:
710.00
Spread: 20.00 (2.899%)
Market Cap: £246.67m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Share Buy-Back Policy

7 Aug 2023 16:25

RNS Number : 5528I
B.P. Marsh & Partners PLC
07 August 2023
 

7 August 2023

 

B.P. Marsh & Partners Plc

("B.P. Marsh" or the "Company")

 

Share Buy-Back Policy

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist venture capital investor in early-stage financial services businesses, wishes to reconfirm the details of the existing Share Buy-Back Programme as announced on 16 January 2023 and updated on 25 April 2023, following the Company's recent Annual General Meeting at which the Company's shareholders generally authorised it to purchase up to a maximum of 3,746,600 Ordinary Shares (the "Authority").

 

The Company announced on 16 January 2023 that it had allocated £1,000,000 to a Share Buy-Back Programme that would buy back shares at a price (the "Price") representing a discount of no less than 20% to the most recently published Net Asset Value per share.

 

As at the date of this announcement, the latest published Net Asset Value per share is 526.2p, and to date the Company has acquired 201,317 Ordinary Shares since commencing the Share Buy-Back Programme for an aggregate consideration of £731,613. The Price will vary in line with the Company's future published Net Asset Value movements.

 

Pursuant to the Authority, any purchases of Ordinary Shares will be carried out independently managed by Panmure Gordon (UK) Limited, who will make the share purchases on the Company's behalf and make all trading decisions independently of, and uninfluenced by, the Company.

 

The Company will announce any market purchase of Ordinary Shares pursuant to the Authority without delay.

 

Separately, as announced on 6 June 2023, the Group plans to commit a further £6,000,000 to further share buy-backs, with more information to follow in due course with regard to mechanics and how best to deliver this.

 

The Company remains committed to its previously stated objective to reduce the share price discount to net asset value and reserves the right to review the discount threshold and budget allocation stated above if, in the opinion of the Company's directors, such action would further enhance shareholder value.

The Company confirms that it currently has no unpublished inside information.

 

All defined terms in this announcement, unless defined herein or the context otherwise requires, shall have the same meaning as defined in the Company's announcements on 16 January 2023 and 25 April 2023 titled 'Interim Dividend Declaration and Share Buy-Back' and 'Share Buy-Back Programme Update', respectively.

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Stephen Jones / Amrit Mahbubani / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson / Katie Hopkins

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fifteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSNKOBBPBKDKFK
Date   Source Headline
16th Jun 20267:01 amRNSFinal Dividend Declaration
16th Jun 20267:00 amRNSNotice of AGM
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:01 amRNSFinal Results for the Year to 31 January 2026
27th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSNotice of Results and Investor Presentation
24th Apr 20265:50 pmRNSTransaction in Own Shares
20th Apr 20265:25 pmRNSSIP Awards, PDMR Dealings, Treasury Shares, TVR
16th Apr 20267:00 amRNSDeferred Consideration Receipt & Special Dividend
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSFollow-on equity purchase in Pantheon
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20263:52 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSNew Share Buyback Programme
18th Mar 20267:00 amRNSNew Investment: Nine Edge Wealth Limited
18th Mar 20267:00 amRNSNew Investment: Ventura Risk Partners Holdings
17th Mar 20264:48 pmRNSSale of Interest in Amiga to Sodalis
11th Mar 20267:00 amRNSUpdate on Sodalis Capital Limited
24th Feb 20267:00 amRNSTrading Update
6th Feb 20267:00 amRNSPurchase of Own Shares and Total Voting Rights
5th Feb 202611:44 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSInterim Dividend Declaration
18th Dec 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
15th Dec 20257:00 amRNSSpecial Dividend Declaration
11th Dec 20257:00 amRNSAppointment of Nominated Adviser and Joint Brokers
2nd Dec 20257:00 amRNSChange in Executive Directorship Roles
27th Nov 20256:17 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSNew Investment: Sodalis Capital Limited
25th Nov 20254:55 pmRNSTransaction in Own Shares
24th Nov 20255:05 pmRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:57 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 202512:38 pmRNS-RB.P. Marsh to present at MelloLondon
11th Nov 20255:08 pmRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:01 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSSale of Stewart Specialty Risk Underwriting
27th Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSHalf-year Results
7th Oct 202511:15 amRNSNotice of HY Results and Investor Presentation
30th Sep 20253:52 pmRNSNew Investment: Oneglobal Broking Holdings Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.